EverHint Lens - Avis Budget Group, Inc. ($CAR, +12.99% today, +390% in a month) - Stock Analysis - April 20, 2026 - a Dramatic Short Squeeze?
Analysis Date: 2026-04-20
Sector: Industrials
Industry: Rental & Leasing Services
Exchange: NASDAQ
Sentiment: 🟣 Mixed 88% confidence
Recent articles on Avis Budget Group (CAR) highlight a dramatic short squeeze fueling stock surges of up to 390% in a month, positioning it among top gainers. However, reports note pullbacks, stalling momentum, high short interest, and cautions on weak fundamentals. Sentiment is mixed, blending excitement over price action with warnings of potential reversals.
Executive Summary
Avis Budget Group, Inc. is currently trading at $558.00 (🟢 +12.99% today) with a market capitalization of $19.71B.
Avis Budget Group, Inc., together with its subsidiaries, provides car and truck rentals, car sharing, and ancillary products and services to businesses and consumers.
Price & Valuation
Current Price: $558.00 (at 2:08 PM ET)
Current Volume: 3.1M
Day Range: $476.00 - $559.44
52-Week Range: $78.71 - $559.44
P/E Ratio: -22.09
DCF Valuation: Not applicable (negative intrinsic value)
DCF model (unlevered) calculated as of 2026-04-20.
Market Context
Major Indices:
- S&P 500: $7104.61 (🔴 -0.30%)
- NASDAQ Composite: $24372.53 (🔴 -0.39%)
- Dow Jones Industrial Average: $49378.82 (🔴 -0.14%)
Peer Comparison
Peer comparison (11 companies):
- CAR - Avis Budget Group, Inc. ($558.00, +13.0%, $19.71B) ← Current
- ENS - EnerSys ($199.53, +0.3%, $7.36B)
- GATX - GATX Corporation ($201.00, +1.3%, $7.14B)
- OMAB - Grupo Aeroportuario del Centro Norte, S.A.B. de C.V. ($116.03, -0.4%, $5.60B)
- IEP - Icahn Enterprises L.P. ($8.05, +4.1%, $5.13B)
- ALK - Alaska Air Group, Inc. ($43.94, -3.2%, $5.04B)
- BCO - The Brink's Company ($114.78, +0.3%, $4.72B)
- SPR - Spirit AeroSystems Holdings, Inc. ($39.50, +0.2%, $4.64B)
- MMS - Maximus, Inc. ($68.38, -1.1%, $3.73B)
- HRI - Herc Holdings Inc. ($111.22, +0.9%, $3.71B)
- LNZA - LanzaTech Global, Inc. ($23.90, +5.9%, $53M)
Financial Performance
Latest Quarter (2025-12-31):
- Revenue: $2.66B
- Net Income: $-747.00M
- EPS: $-21.25
- Revenue Growth (QoQ): -24.3%
Dividend Analysis
Dividend Status: ⚠️ Formerly dividend-paying (discontinued)
Last Dividend:
- Amount: $10.00 per share
- Ex-Dividend Date: 2023-12-14 (2.3 years ago)
- Payment Date: 2023-12-21
Note: This company has not paid dividends in over 2 years. The dividend program appears to have been discontinued.
Payment History: 12 historical dividend payments tracked
Stock Split History
CAR has executed 9 stock split(s) historically
- 2006-09-05: 1-for-10 split
- 2006-08-01: 25-for-4 split
- 1996-10-22: 3-for-2 split
- 1995-07-03: 3-for-2 split
- 1993-05-03: 3-for-2 split
- 1992-07-06: 3-for-2 split
- 1991-03-01: 3-for-2 split
- 1986-07-21: 3-for-2 split
- 1985-03-19: 3-for-2 split
Cumulative Split Factor: 11x (1 share in 1987 = 11 shares today)
Most recent split: 1-for-10 on 2006-09-05
Earnings Calendar
Next Earnings Report: 2026-05-06 (After Market Close)
- EPS Estimate: $-7.00
- Revenue Estimate: $2.43B
Most Recent Report: 2026-02-18
- EPS: $-6.53 (Est: $-0.29) ✗ Miss
- Revenue: $2.66B
Historical Data: 162 earnings events tracked
Analyst Outlook
Analyst Price Target Consensus:
- Target: $119.25 (-78.6% upside)
- Range: $85.00 - $142.00
- Median: $125.00
Next Quarter Estimates (2027-12-31):
- Revenue: $2.70B
- EPS: $-1.28
Analyst Consensus
Overall Rating: Buy
Rating Distribution (256 total ratings):
- 🟢 Buy/Outperform: 80 (31.2%)
- ⚪ Hold/Neutral: 72 (28.1%)
- 🔴 Sell/Underperform: 49 (19.1%)
Recent Analyst Actions:
- Barclays (2026-04-20): Downgrade Equal-Weight → Underweight
- Susquehanna (2025-10-29): Maintain Neutral
- Deutsche Bank (2025-07-10): Maintain Buy
Consensus based on 256 analyst ratings from major financial institutions
Trading Signals
Our technical analysis identified 1 trading signal(s) in the last 60 days:
- 2026-03-25: Ema10 Ema30 - EMA10_x_EMA30_Buy @ $123.56
Insider Activity
Recent Transactions (Last 10):
- Buys: 4
- Sells: 6
Notable Transactions:
- 2026-03-20: Pentwater Capital Management LP - Buy (X-InTheMoney, 4,300 shares @ $130.00)
- 2026-03-20: Pentwater Capital Management LP - Buy (X-InTheMoney, 53,800 shares @ $125.00)
- 2026-03-20: Pentwater Capital Management LP - Buy (X-InTheMoney, 376,600 shares @ $120.00)
Congressional Trading Activity
Tracking recent stock transactions by U.S. Congress members
House of Representatives: 1 transactions tracked
Recent Activity:
- 🟢 Daniel Goldman (NY10): Purchase on 2023-04-10 @ $190.69, Amount: $1,001 - $15,000
Congressional trading data sourced from official disclosure filings
News Sentiment Analysis
AI Analysis (based on 30 recent articles):
Recent news on Avis Budget Group (CAR) highlights a dramatic short squeeze propelling the stock up over 300% in a month, with multiple reports of surges, new highs, and heavy call buying. However, coverage also notes signs of stalling momentum, pullbacks, high short interest, and analyst downgrades signaling caution. Overall sentiment is positive driven by price action but tempered by risks.
Key Themes:
- Short Squeeze
- Stock Surge
- Bearish Pressures
Sentiment: Positive (80% confidence)
Reddit Sentiment
Community Discussion (last 30 days from r/wallstreetbets, r/stocks, r/investing):
Overall Sentiment: Strongly Bullish 📈📈 (Score: 0.358)
Post Analysis:
- Total posts: 59
- Bullish: 44 (74.6%)
- Bearish: 14 (23.7%)
- Neutral: 1 (1.7%)
- Total engagement: 25,296 (upvotes + comments)
Note: Sentiment score ranges from -1.0 (very bearish) to +1.0 (very bullish), weighted by post engagement.
Recent News
5 most recent articles covering CAR:
- Avis, CarMax, and Carvana: 3 Car Stocks Sharply Diverge (marketbeat.com, 2026-04-20) — Read more
- Avis Budget Group Stock Rising Monday: What's Driving The Action? (benzinga.com, 2026-04-20) — Read more
- Avis Budget: Looking Beyond The Short Squeeze (forbes.com, 2026-04-20) — Read more
- Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies (prnewswire.com, 2026-04-20) — Read more
- Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies (prnewswire.com, 2026-04-20) — Read more
Full news analysis based on 30 recent articles
Generated by Everhint Lens - Quantitative Stock Analysis
Last updated: 2026-04-20 11:09:00 AM PDT
Disclaimer: This is not investment advice. Always do your own research before making investment decisions.